Journals / Anatolian Current Medical Journal / 2023 / Cilt: 5 Sayı: 3

The effect of mask use on allergic rhinitis symptoms during COVID-19 pandemic

Pages
266–269
Publication Date
2023-07-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:Although studies with larger patient and control groups are needed, we think that the use of face masks during the COVID-19 pandemic is an effective protective measure for protection from pollen in patients with allergic rhinitis,who have pollen sensitivity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Inspiratory particle load including the allergens in the inhaled air is decreased by the use of the mask, which is one of the methods for COVID-19 protection.
📊
Key Findings & Data:Results:The frequency of nasal discharge (6.62±1.69; 6.00±1.89: p<0.001), obstruction (4.56±1.64; 4.28±1.86: p=0.099), itching(7.49±1.55; 7.16±1.83: p=0.038), sneezing (5.54±1.60; 5.21±1.89: p=0.046), and frequency of drug use (5.52±1.62; 5.17±1.91: p=0.037) decreased statistically significantly after the pandemic according to the visual analog scoring.
💡
Conclusion & Impact:Conclusion:Although studies with larger patient and control groups are needed, we think that the use of face masks during the COVID-19 pandemic is an effective protective measure for protection from pollen in patients with allergic rhinitis,who have pollen sensitivity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mask usage · allergic rhinitis · COVID-19

Abstract

Aims: Inspiratory particle load including the allergens in the inhaled air is decreased by the use of the mask, which is one of the methods for COVID-19 protection. The aim of the study is to investigate the effect of masks used by seasonal allergic rhinitis patients with pollen allergy on the control of rhinitis symptoms. Methods: Mask usage characteristics of patients (mask type used, average number of days per week for mask usage, daily usage time),whether there was a change in the time spent outdoors during the pandemic compared to the pre-pandemic period, and rhinitis complaints and frequency of rhinitis-related drug use before the pandemic compared to the pandemic period were investigated. Results:The frequency of nasal discharge (6.62±1.69; 6.00±1.89: p<0.001), obstruction (4.56±1.64; 4.28±1.86: p=0.099), itching(7.49±1.55; 7.16±1.83: p=0.038), sneezing (5.54±1.60; 5.21±1.89: p=0.046), and frequency of drug use (5.52±1.62; 5.17±1.91: p=0.037) decreased statistically significantly after the pandemic according to the visual analog scoring. However, an increase was found in ocular symptoms. Conclusion:Although studies with larger patient and control groups are needed, we think that the use of face masks during the COVID-19 pandemic is an effective protective measure for protection from pollen in patients with allergic rhinitis,who have pollen sensitivity.

🔖

Cite This Article

BAHÇECİOĞLU, S. N., ATEŞ, H., KALKAN, İ. K., AKSU, K., DEMİR, Ş., TOPEL, M., YEŞİLKAYA, S. (2023). The effect of mask use on allergic rhinitis symptoms during COVID-19 pandemic. Anatolian Current Medical Journal, Cilt: 5 Sayı: 3, 266–269. https://ajindex.com/articles/956852

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207. World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  2. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-469.
  3. Klimek L, Huppertz T, Alali A, et al. A new form of irritant rhinitis to filtering facepiece particle (FFP) masks (FFP2/N95/KN95 respirators) during COVID-19 pandemic. World Allergy Organ J. 2020;13(10):100474. Klimek L, Jutel M, Akdis C, et al. ARIA-MASK Study Group. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020;75(7):1546-1554.
  4. Cherrie JW, Apsley A, Cowie H, et al. Effectiveness of face masks used to protect Beijing residents against particulate air pollution. Occup Environ Med. 2018;75(6):446-452.
  5. Oberg T, Brosseau LM. Surgical mask filter and fit performance. Am J Infect Control. 2008;36(4):276-282.
  6. Lee SA, Grinshpun SA, Reponen T. Respiratory performance offered by N95 respirators and surgical masks: human subject evaluation with NaCl aerosol representing bacterial and viral particle size range. Ann OccupHyg. 2008;52(3):177-185.
  7. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4): 721-767. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2-8. Schröder K, Finis D, Meller S, Buhren BA, Wagenmann M, Geerling G. Die saisonale und perenniale allergische rhinokonjunktivitis [seasonal and perennial allergic rhinoconjunctivitis]. Laryngorhinootologie. 2017;96(2):89-97.
  8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94(2 Pt 1):182-188.
  9. Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. J Asthma Allergy. 2017;10:47-56.
  10. Kef K, Güven S. The prevalence of allergic rhinitis and associated risk factors among university students in anatolia. J Asthma Allergy. 2020;13:589-597.
  11. Dror AA, Eisenbach N, Marshak T, et al. Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic